Cargando…

Initial low‐dose oral levothyroxine in a child with Down syndrome, myxedema, and cardiogenic shock

Myxedema is extremely rare in children, and guidelines are lacking. We treated a 12‐year‐old girl with myxedema and cardiogenic shock with initial low dose (0.3‐2.5 μg/kg body weight/day) of oral levothyroxine and intensive care. Oral administration may safely revert children's myxedema in a do...

Descripción completa

Detalles Bibliográficos
Autores principales: Janson, Annika, Hällström, Cathrin, Iversen, Magnus, Finder, Mikael, Elimam, Amira, Nergårdh, Ricard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637322/
https://www.ncbi.nlm.nih.gov/pubmed/31360469
http://dx.doi.org/10.1002/ccr3.2169
_version_ 1783436219818967040
author Janson, Annika
Hällström, Cathrin
Iversen, Magnus
Finder, Mikael
Elimam, Amira
Nergårdh, Ricard
author_facet Janson, Annika
Hällström, Cathrin
Iversen, Magnus
Finder, Mikael
Elimam, Amira
Nergårdh, Ricard
author_sort Janson, Annika
collection PubMed
description Myxedema is extremely rare in children, and guidelines are lacking. We treated a 12‐year‐old girl with myxedema and cardiogenic shock with initial low dose (0.3‐2.5 μg/kg body weight/day) of oral levothyroxine and intensive care. Oral administration may safely revert children's myxedema in a dosage resembling that for hypothyroidism.
format Online
Article
Text
id pubmed-6637322
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-66373222019-07-29 Initial low‐dose oral levothyroxine in a child with Down syndrome, myxedema, and cardiogenic shock Janson, Annika Hällström, Cathrin Iversen, Magnus Finder, Mikael Elimam, Amira Nergårdh, Ricard Clin Case Rep Case Reports Myxedema is extremely rare in children, and guidelines are lacking. We treated a 12‐year‐old girl with myxedema and cardiogenic shock with initial low dose (0.3‐2.5 μg/kg body weight/day) of oral levothyroxine and intensive care. Oral administration may safely revert children's myxedema in a dosage resembling that for hypothyroidism. John Wiley and Sons Inc. 2019-05-20 /pmc/articles/PMC6637322/ /pubmed/31360469 http://dx.doi.org/10.1002/ccr3.2169 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Janson, Annika
Hällström, Cathrin
Iversen, Magnus
Finder, Mikael
Elimam, Amira
Nergårdh, Ricard
Initial low‐dose oral levothyroxine in a child with Down syndrome, myxedema, and cardiogenic shock
title Initial low‐dose oral levothyroxine in a child with Down syndrome, myxedema, and cardiogenic shock
title_full Initial low‐dose oral levothyroxine in a child with Down syndrome, myxedema, and cardiogenic shock
title_fullStr Initial low‐dose oral levothyroxine in a child with Down syndrome, myxedema, and cardiogenic shock
title_full_unstemmed Initial low‐dose oral levothyroxine in a child with Down syndrome, myxedema, and cardiogenic shock
title_short Initial low‐dose oral levothyroxine in a child with Down syndrome, myxedema, and cardiogenic shock
title_sort initial low‐dose oral levothyroxine in a child with down syndrome, myxedema, and cardiogenic shock
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637322/
https://www.ncbi.nlm.nih.gov/pubmed/31360469
http://dx.doi.org/10.1002/ccr3.2169
work_keys_str_mv AT jansonannika initiallowdoseorallevothyroxineinachildwithdownsyndromemyxedemaandcardiogenicshock
AT hallstromcathrin initiallowdoseorallevothyroxineinachildwithdownsyndromemyxedemaandcardiogenicshock
AT iversenmagnus initiallowdoseorallevothyroxineinachildwithdownsyndromemyxedemaandcardiogenicshock
AT findermikael initiallowdoseorallevothyroxineinachildwithdownsyndromemyxedemaandcardiogenicshock
AT elimamamira initiallowdoseorallevothyroxineinachildwithdownsyndromemyxedemaandcardiogenicshock
AT nergardhricard initiallowdoseorallevothyroxineinachildwithdownsyndromemyxedemaandcardiogenicshock